The Claim
In patients with atherosclerotic cardiovascular disease who achieve LDL cholesterol levels below 70 mg/dL on moderate-intensity statin therapy, further intensification of lipid-lowering treatment is associated with a 36% reduction in the rate of coronary revascularization procedures, as indicated by a hazard ratio of 0.64 (95% confidence interval: 0.43–0.96; p=0.029).
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
If someone with heart disease already has low 'bad' cholesterol on standard statin pills, stepping up their treatment even more can cut the chance of needing heart procedures like stents or bypass surgery by more than a third.
See the scientific wording
In patients with atherosclerotic cardiovascular disease who achieve LDL-C <70 mg/dL on moderate-intensity statins, escalating lipid-lowering therapy is associated with a 36% lower rate of coronary revascularization (HR 0.64; 95% CI: 0.43–0.96; p=0.029), indicating a meaningful reduction in the need for procedures like stenting or bypass surgery.
What the research says
1 studyThe study found that stepping up cholesterol treatment reduced the need for heart procedures like stents or bypass surgery, which supports the claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.